New method aims to help prisoners understand research consent
NCT ID NCT06378281
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new method to help prisoners better understand what they are agreeing to when joining a research study. Researchers will compare an enhanced 'teach-to-goal' consent process with the standard one in 100 adults with ADHD in prison. The goal is to improve ethical practices for vulnerable populations.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better informed consent procedures for prisoners and other vulnerable groups, making research more ethical and trustworthy.
- What could go wrong
- This is a small, early-stage study (100 participants) testing a procedure, not a treatment. Results may not apply to all prisons or populations, and the method may not improve understanding as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADHD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Geneva University Hospitals
NOT_YET_RECRUITINGGeneva, Canton of Geneva, 1211, Switzerland
-
Geneva University Hospitals
RECRUITINGGeneva, Canton of Geneva, 1226, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Peeking inside the ADHD brain: can two drugs rewire attention circuits?
- Can a common ADHD drug help kids with down syndrome?
- Could a gut makeover ease ADHD? a trial tests FMT in teens
- Can a virtual classroom train young brains to tune out distractions?
- A common antidepressant may tame anxiety in kids with autism and ADHD — a trial puts it to the test
- Could a new drug help teens with ADHD?